News Releases

Vitamin Shoppe, Inc. Announces Fourth Quarter 2018 Results
Fourth Quarter 2018 Highlights:
- Gross Profit Margin Increases 210 basis points
- Total Comparable Sales (4.7%)
- Digital commerce (0.1%); excluding marketplaces ecommerce sales increased 8.6%.
- GAAP net loss per share from continuing operations of $0.14. Adjusted net loss per share from continuing operations of $0.19
- Repurchased $8.0 million face value of December 2020 convertible notes
- Introduces 2019 Guidance

SECAUCUS, N.J., Feb. 26, 2019 /PRNewswire/ -- Vitamin Shoppe, Inc. (NYSE: VSI), an omni-channel, specialty retailer of nutritional products, today announced preliminary results for the three and twelve months ended December 29, 2018.  Total net sales in the fourth quarter were $248.5 million compared to $261.9 million in the same period of the prior year.  Total net sales in full year 2018 were $1,114.2 million compared to $1,146.5 million in the same period of the prior year.

Reported net loss per share from continuing operations in fourth quarter 2018 was $0.14, compared to a net loss per share from continuing operations of $0.66 in the same period of the prior year.  Excluding special items in both 4Q18 and 4Q17 as shown in Table 4 at the end of this press release, loss per share from continuing operations was $0.19 in fourth quarter 2018 compared with earnings per share of $0.02 in fourth quarter 2017.  Reported net income per share from continuing operations in 2018 was $0.58, compared to a net loss per share from continuing operations of $10.17 in the same period of the prior year.  Excluding special items in both 2018 and 2017 as shown in Table 4 at the end of this press release, earnings per share from continuing operations was $0.26 in 2018 compared with earnings per share of $0.80 in 2017.

Commenting on the results, Sharon Leite, Chief Executive Officer stated, "We are encouraged by our performance year over year as we continue to accelerate our evolution to an even more customer-centric health, wellness and fitness retailer.  Full year comparable sales performance has improved relative to the prior year and importantly we are still seeing margin improvement.  Lastly, we ended the year with a healthy balance sheet and solid free cash flow after re-purchasing $83.3 million face value of our convertible notes in 2018."

"Our team is committed to turning around the business, revitalizing the Brand and successfully placing the company on a growth trajectory.  I am confident in our ability to do so.  We are well positioned to capitalize on opportunities ahead of us and add significant value for our shareholders.  The fundamentals have been put in place and now successful execution is the focus," concluded Ms. Leite.

Fourth Quarter 2018 Results

Total sales of $248.5 million in the quarter were 5.1% lower than the same period of the prior year.  Total comparable sales were down 4.7% in the quarter comprised of a negative 5.4% for comparable store sales and negative 0.1% for comparable digital sales.  The Company closed six stores in the quarter and did not open any new ones.

Cost of goods sold, which includes product, distribution and store occupancy costs, were $167.7 million, 8.0% lower than the same period of the prior year, primarily attributable to the lower sales.  Fourth quarter 2018 included a $0.2 million benefit while 2017 included $0.8 million in net expenses related to the closure of the New Jersey distribution center.

Gross profit was $80.8 million, up from $79.6 million reported in fourth quarter 2017.  Reported gross profit as a percentage of net sales was 32.5% in fourth quarter 2018, compared to 30.4% in the same period of 2017.  Excluding the special items shown in Table 4 at the end of this press release, gross profit was $80.6 million in fourth quarter 2018 and as a percentage of sales was 32.4% compared to gross profit of $80.4 million and gross margin rate of 30.7% in 4Q17.  The fourth quarter 2018 year-over-year increase was primarily due to improvements in product margin partially offset by deleverage in supply chain and occupancy. 

Selling, general and administrative expenses (SG&A), including operating payroll and related benefits and advertising expense, was $84.7 million for the quarter ended December 29, 2018, compared with $86.0 million for the quarter ended December 30, 2017.  SG&A as a percent of revenue was 34.1% in fourth quarter 2018 compared with 32.8% in fourth quarter 2017.  Adjusted for the items shown in Table 4, for both years, SG&A as a percentage of sales was 33.8% compared to 32.8% in fourth quarter 2017. 

The Company recorded a $1.5 million store fixed asset impairment expense in 4Q18 compared with a $0.8 million expense in 4Q17.

Operating loss in fourth quarter 2018 was $5.4 million compared to an operating loss of $7.2 million in the same period of the prior year.  Adjusted for the items noted in Table 4 for both fourth quarters 2018 and 2017, adjusted operating loss was $5.0 million in fourth quarter 2018 compared with an adjusted operating loss of $6.3 million in fourth quarter 2017.  (Refer to Table 4 at the end of this press release for a reconciliation.) 

Reported net loss from continuing operations was $3.3 million for fourth quarter 2018 compared to net loss from continuing operations of $15.4 million in the same period of the prior year. 

Reported loss per share was $0.23 in fourth quarter 2018, compared to a loss per share of $0.75 in fourth quarter 2017.  Loss per share from continuing operations was $0.14 in fourth quarter 2018 compared to loss per share from continuing operations of $0.66 in fourth quarter 2017.  Loss per share from continuing operations on an adjusted basis (for the items described in Table 4) in fourth quarter 2018 was $0.19 compared to earnings per share of $0.02 in fourth quarter 2017.

Balance Sheet and Cash Flow

Cash and equivalents at December 29, 2018 were $2.7 million.  During the quarter the Company repurchased $8.0 million face value of convertible notes due December 2020 at a discounted price of $6.7 million, resulting in a $0.7 million pre-tax gain from the early extinguishment of debt.  At quarter end, the Company had a convertible notes liability with a total face value of $60.4 million and nothing borrowed on its revolving line of credit.  Inventory was down $29 million, or 13%, from year-end 2017.

Capital expenditures were $3.5 million in the quarter with funds primarily expended on IT and other digital investments.

Fiscal Year 2018 Operating and Financial Highlights:

- Total Comparable Sales (2.8%)

- Digital commerce increases 18.9%

- Repurchased $83.3 million face value of convertible notes

- $16.9 million gain on early extinguishment of debt

- GAAP earnings per share (EPS) from continuing operations of $0.58.  Adjusted EPS from continuing operations of $0.26

- Opened 2 stores and closed 13

- Total capital expenditures were $28.1 million

- Sold Nutri-Force, contract manufacturing business

2019 Outlook

The Company is providing guidance around the key levers that drive the business. Specifically:

  • Full year comparable sales of negative low single digits to flat
  • Reported full year gross margin rate of 31.7% to 32.2%.
  • Adjusted EBITDA of $62 million to $65 million.
  • Estimated combined Federal, State and Local tax rate of 28%.
  • Full year capital expenditures of approximately $33 million, and includes the opening of approximately 10 new stores.
  • Closing approximately 60 to 80 stores over next three years

Non-GAAP Financial Measures
Adjusted information is non-GAAP financial information. These supplemental non-GAAP measures should not be considered superior to, or a substitute for, and should be considered in conjunction with the GAAP financial measures presented.  The Company believes such non-GAAP financial information facilitates analysis and comparisons of our ongoing business operations because it excludes items that may not be indicative of, or are unrelated to the Company's core operating performance, and may assist investors with comparisons to prior periods and assessing trends in our underlying business. These adjustments are consistent with how management views our business. Management uses such non-GAAP financial information in making financial, operating and planning decisions and evaluating the Company's ongoing performance. A reconciliation of adjusted financial information to the most directly comparable financial measures calculated and presented in accordance with GAAP is shown in Table 4.

The Company defines Adjusted EBITDA as EBITDA (net income (loss) before interest expense, net, provision (benefit) for income taxes, depreciation and amortization), as further adjusted to exclude the effects of certain income and expense items that management believes make it more difficult to assess the Company's actual operating performance including certain items which are generally non-recurring.  The Company has excluded the impact of such items from internal performance assessments.  The Company believes that excluding such items helps investors compare operating performance with the results in prior periods.  The Company believes it is appropriate to exclude these items as they are not related to ongoing operating performance and, therefore, limit comparability between periods and between The Vitamin Shoppe and similar companies.

A reconciliation of the projected Adjusted EBITDA which is a forward-looking non-GAAP financial measure, to projected net income is not provided because the company is unable to provide such reconciliation without unreasonable effort. The inability to provide a reconciliation is due to the uncertainty and inherent difficulty predicting the individual items that are added to, or subtracted from, net income in order to derive Adjusted EBITDA.

Webcast
Management will host a conference call to discuss the fourth quarter 2018 results at 8:30 a.m. Eastern Time (ET) today.  Interested investors and other parties may listen to the simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.vitaminshoppe.com.  A telephonic replay will be available beginning at 11:30 a.m. ET on February 26, 2019 and can be accessed by dialing 1-844-512-2921 or 1-412-317-6671 for international callers.  The passcode for the replay is 1499639.  The telephonic replay will be available until 11:59 p.m. ET on March 12, 2019.  The webcast will also be archived on the company's website at www.vitaminshoppe.com in the investor relations section.

About the Vitamin Shoppe, Inc. (NYSE: VSI)
Vitamin Shoppe is an omni-channel, specialty retailer of nutritional products based in Secaucus, New Jersey.  In its stores and on its website, the Company carries a comprehensive retail assortment including: vitamins, minerals, specialty supplements, herbs, sports nutrition, homeopathic remedies, green living products, and beauty aids.  In addition to offering products from approximately 700 national brands, the Vitamin Shoppe also carries products under The Vitamin Shoppe®, BodyTech®, True Athlete®, MyTrition®, plnt®, ProBioCare®, and Next Step® brands.  The Vitamin Shoppe conducts business through more than 750 company-operated retail stores under The Vitamin Shoppe and Super Supplements retail banners, and through its website, www.vitaminshoppe.com.  Follow the Vitamin Shoppe on Facebook at http://www.facebook.com/THEVITAMINSHOPPE and on Twitter at http://twitter.com/VitaminShoppe.

Forward Looking Statements
This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, those that contain, or are identified by, words such as "outlook", "guidance", "believes", "expects", "potential", "continues", "may", "will", "should", "predicts", "intends", "plans", "estimates", "anticipates", "could" or the negative version of these words or other comparable words.  These statements are subject to various risks and uncertainties, many of which are outside our control, including, among others, strength of the economy, changes in the overall level of consumer spending, the performance of the Company's products within the prevailing retail environment, implementation of our strategy,  compliance with regulations, certifications and best practices with respect to the development, manufacture, sale and marketing of the Company's products, management changes, maintaining appropriate levels of inventory, changes in tax policy, ecommerce relationships, disruptions of manufacturing, warehouse or distribution facilities or information systems, regulatory  environment and other specific factors discussed herein and in other Securities and Exchange Commission (the "SEC") filings by us (including our reports on Forms 10-K and 10-Q filed with the SEC).  We believe that all forward-looking statements are based on reasonable assumptions when made; however, we caution that it is impossible to predict actual results or outcomes or the effects of risks, uncertainties or other factors on anticipated results or outcomes with certainty and that, accordingly, one should not place undue reliance on these statements. Forward-looking statements speak only as of the date when made and we undertake no obligation to update these statements in light of subsequent events or developments. Actual results may differ materially from anticipated results or outcomes discussed in any forward-looking statement.

 

TABLE 1

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share data)

(Unaudited)






Three Months Ended


Fiscal Year Ended



December 29,


December 30,


December 29,


December 30,



2018


2017


2018


2017










Net sales


$         248,457


$         261,900


$       1,114,160


$       1,146,499

Cost of goods sold


167,702


182,254


759,367


783,932

Gross profit


80,755


79,646


354,793


362,567

Selling, general and administrative expenses


84,684


86,031


344,947


332,199

Goodwill, tradename and store fixed-assets impairment charges


1,466


786


3,017


274,876

Income (loss) from operations


(5,395)


(7,171)


6,829


(244,508)

Gain on extinguishment of debt


673


-


16,902


-

Interest expense, net


1,173


2,489


6,602


9,701

Income (loss) before provision (benefit) for income taxes


(5,895)


(9,660)


17,129


(254,209)

Provision (benefit) for income taxes


(2,616)


5,782


3,588


(18,882)

Net income (loss) from continuing operations


(3,279)


(15,442)


13,541


(235,327)

Net loss from discontinued operations, net of tax


(2,048)


(2,136)


(17,293)


(16,824)

Net loss


$           (5,327)


$         (17,578)


$           (3,752)


$        (252,151)










Weighted average common shares outstanding









   Basic


23,553,417


23,339,565


23,496,841


23,137,977

   Diluted


23,553,417


23,339,565


23,496,841


23,137,977










Net income (loss) from continuing operations per common share









   Basic


$             (0.14)


$             (0.66)


$              0.58


$           (10.17)

   Diluted


$             (0.14)


$             (0.66)


$              0.58


$           (10.17)










Net loss from discontinued operations per common share









   Basic


$             (0.09)


$             (0.09)


$             (0.74)


$             (0.73)

   Diluted


$             (0.09)


$             (0.09)


$             (0.74)


$             (0.73)










Net loss per common share









   Basic


$             (0.23)


$             (0.75)


$             (0.16)


$           (10.90)

   Diluted


$             (0.23)


$             (0.75)


$             (0.16)


$           (10.90)










 

 

TABLE 2

VITAMIN SHOPPE, INC. AND SUBSIDIARY

KEY PERFORMANCE INDICATORS AND STORE INFO

($ in thousands)

(Unaudited)






Three Months Ended


Fiscal Year Ended



December 29,


December 30,


December 29,


December 30,



2018


2017


2018


2017










Decrease in total comparable net sales

(4.7)%


(4.6)%


(2.8)%


(6.5)%

Decrease in comparable store net sales

(5.4)%


(7.0)%


(5.4)%


(6.9)%

Increase (Decrease) in digital comparable net sales

(0.1)%


15.3 %


18.9 %


(3.6)%










Gross profit from continuing operations as a percent of net sales

32.5 %


30.4 %


31.8 %


31.6 %

Income (Loss) from continuing operations as a percent of net sales

(2.2)%


(2.7)%


0.6 %


(21.3)%










Capital Expenditures

$                 3,483


$               11,706


$               28,138


$               55,020

Depreciation and Amortization 

$               10,112


$               10,996


$               42,114


$               39,204










Store Data:









Stores open at beginning of period 

780


784


785


775


    Stores opened 


3


2


15


    Stores closed 

(6)


(2)


(13)


(5)


Stores open at end of period

774


785


774


785










Total retail square footage at end of period (in thousands)

2,702


2,737


2,702


2,737










 

TABLE 3

VITAMIN SHOPPE, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)





December 29,


December 30,


2018


2017

ASSETS




Current assets:




  Cash and cash equivalents

$                  2,668


$                   1,947

  Inventories

189,273


218,087

  Prepaid expenses and other current assets

27,921


39,473

  Current assets held for sale

-


22,625

     Total current assets

219,862


282,132

Property and equipment, net

123,002


141,520

Intangibles, net

11,088


11,040

Deferred taxes

31,659


37,278

Other long-term assets

2,468


2,572

Noncurrent assets held for sale

-


16,891

Total assets

$              388,079


$               491,433





LIABILITIES AND STOCKHOLDERS' EQUITY 




Current liabilities:




  Revolving credit facility

$                         -


$                 12,000

  Accounts payable

39,789


46,921

  Deferred sales

5,455


5,710

  Accrued expenses and other current liabilities

60,553


56,935

  Current liabilities held for sale

-


5,337

     Total current liabilities

105,797


126,903

Convertible notes, net

55,570


126,415

Deferred rent

37,034


40,832

Other long-term liabilities 

1,337


1,916





Commitments and contingencies








Stockholders' equity:




  Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued




   and outstanding at December 29, 2018 and December 30, 2017

-


-

  Common stock, $0.01 par value; 400,000,000 shares authorized, 24,234,651 shares issued and




  23,974,031 shares outstanding at December 29, 2018, and 24,220,509 shares issued and 24,021,948




  shares outstanding at December 30, 2017

242


242

  Additional paid-in capital

85,853


88,823

  Treasury stock, at cost; 260,620 shares at December 29, 2018 and 198,561 shares at December 30, 2017

(7,314)


(7,010)

  Retained earnings 

109,560


113,312

           Total stockholders' equity 

188,341


195,367

Total liabilities and stockholders' equity

$              388,079


$               491,433





 

 

TABLE 4

VITAMIN SHOPPE, INC. AND SUBSIDIARY

SUPPLEMENTAL OPERATING DATA

(Unaudited)




Amounts in millions except per share data












Figures may not sum due to rounding













Gross




Goodwill,
Tradename
and Store
Fixed-Assets
Impairment


Operating 


Net


Diluted

Continuing Operations

Profit


SG&A


Charges


Income (Loss)


Income (Loss)


EPS













Three months ended December 29, 2018:












 As Reported

$           80.8


$           84.7


$                  1.5


$                 (5.4)


$                 (3.3)


$                  (0.14)

Tax carryback (1)

-


-


-


-


(1.1)


(0.05)

Gain on extinguishment of debt (2)

-


-


-


-


(0.5)


(0.02)

Management realignment charges (3)

-


(0.6)


-


0.6


0.4


0.02

Closing of distribution center (4)

(0.2)


-


-


(0.2)


(0.1)


(0.01)













 As Adjusted

$             80.6


$             84.1


$                   1.5


$                  (5.0)


$                  (4.5)


$                   (0.19)













Three months ended December 30, 2017:












 As Reported

$           79.6


$           86.0


$                  0.8


$                 (7.2)


$               (15.4)


$                  (0.66)

Impact of Tax Reform Act (5)

-


-


-


-


15.3


0.66

Closing of distribution center (4)

0.8


-


-


0.8


0.5


0.02













 As Adjusted

$             80.4


$             86.0


$                   0.8


$                  (6.3)


$                    0.4


$                     0.02













Fiscal year ended December 29, 2018:












 As Reported

$         354.8


$         344.9


$                  3.0


$                  6.8


$                 13.5


$                   0.58

Gain on extinguishment of debt (2)

-


-


-


-


(12.1)


(0.51)

Inventory charge (6)

3.6


-


-


3.6


2.6


0.11

Management realignment charges (3)

-


(2.8)


-


2.8


2.0


0.09

Closing of distribution center (4)

1.6


(1.1)


-


2.7


2.0


0.08

Tax Reform (7)

-


-


-


-


(1.3)


(0.06)

Tax carryback (1)

-


-


-


-


(1.1)


(0.05)

Shareholder settlement (8)

-


(0.7)


-


0.7


0.5


0.02













 As Adjusted

$           360.0


$           340.3


$                   3.0


$                 16.7


$                    6.1


$                     0.26













Fiscal year ended December 30, 2017:












 As Reported

$         362.6


$         332.2


$              274.9


$            (244.5)


$             (235.3)


$               (10.17)

Impairment charges on goodwill (9)

-


-


(210.6)


210.6


197.6


8.54

Impairment charge on tradename (10)

-


-


(59.4)


59.4


36.6


1.58

Impact of Tax Reform Act (5)

-


-


-


-


15.3


0.66

Store impairment charges (11)

-


-


(3.8)


3.8


2.3


0.10

Closing of distribution center (4)

2.8


(0.3)


-


3.1


1.9


0.08













 As Adjusted

$           365.4


$           331.9


$                   1.1


$                 32.4


$                  18.4


$                     0.80













(1) Represents the tax benefit resulting from a tax credit carryback.

(2) Gain recognized on the repurchases of a portion of Convertible Notes, net of tax.

(3) Costs related to management turnover, including severance charges, recruitment costs and related professional fees.

(4) Costs related to the closing of the North Bergen, New Jersey distribution center.

(5) Tax expense resulting from the change in valuation of deferred tax assets under the Tax Cut and Jobs Act of 2017.

(6) Inventory charge resulting from an evaluation to optimize the Company's product assortment.

(7) Represents the tax benefit associated with tax accounting method changes and their effect on the revalued deferred tax assets and liabilities under the Tax Cut
      and Jobs Act of 2017.

(8) Professional fees incurred related to shareholder settlement.

(9) Impairment charges on the goodwill of the retail operations.

(10) Impairment charge on the Vitamin Shoppe tradename.

(11) Impairment charges on the fixed assets of retail locations.

 

 

 

SOURCE Vitamin Shoppe, Inc.

For further information: Analysts and Investors: Kathleen Heaney, 646-912-3844 OR 201-552-6430, ir@vitaminshoppe.com